DIOSYNTH
LIVE

Serial Number

99232608

Owner

FUJIFILM Corporation

Attorney

Suzanne M. Hengl

Filing Date

Jun 13, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DIOSYNTH Trademark

Serial Number: 99232608

DIOSYNTH is a trademark filed by FUJIFILM Corporation on June 13, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

FUJIFILM Corporation

26-30, Nishiazabu 2-chome, Minato-ku
Tokyo 106-8620 , JP

Entity Type: 03

Trademark Details

Filing Date

June 13, 2025

Registration Date

Not Registered

Goods & Services

Services of biotechnical, chemical and pharmacological laboratories, namely, scientific and technological research, namely, production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations; scientific and technological research, namely, production of chemicals and biotechnological products for use in preparing pharmaceutical and veterinary preparations, and scientific research consultation related thereto; scientific research, namely, conducting early evaluations in the field of new pharmaceutical medicines; development of products for others, namely, pharmaceutical preparations, medicines and medicaments; technological services, namely, technological consultation and research as related to medical products in the field of new product development in the pharmaceutical and health care industries; scientific analysis and research, namely, evaluation of pharmaceutical products; research and development in the field of pharmaceutical medicines; scientific research and development in the field of medicines; product development for others, namely, preparation of pharmaceutical test products; advisory services relating to the field of scientific research, development and analyses of medicines; development of new technologies for others in the biotechnology sector; providing information about scientific research in the field of biochemistry and biotechnology; scientific research for the medical sector in the field of cancerous diseases

Chemical preparations and substances, namely, chemical additives for use in the manufacturing of pharmaceutical products, namely, chemical preparations and substances for manufacturing pharmaceutical products for veterinary applications; chemical additives for manufacturing medicines, namely, pharmaceuticals; Chemicals, namely, chemical additives for use in the manufacturing of cosmetics, skin cleansers and medicines, namely, pharmaceuticals; chemical preservatives for use in the production of a wide variety for chemicals for pharmaceutical preparations; Biochemicals, namely, polypeptides, recombinant proteins, organic peptide substrates and monoclonal antibodies for scientific purposes, namely, genetic pharmacology

Custom manufacture of pharmaceuticals.

Medicines and pharmaceutical products, namely medicines and pharmaceutical products for veterinary use, namely, medicines and pharmaceutical preparations for the treatment and prevention of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital disorders and, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory disease, respiratory and infectious diseases, immunological, bacterial, viral and fungal disorders, mental illness, depression, psychosis, bone and mineral diseases, infertility, menopausal complaints, hormone deficiencies, and sleep disorders; Medical pharmaceutical preparations, namely, preparations for lowering cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations, contraceptives, muscle relaxants, muscle relaxant antagonists; biotechnological preparations, namely, pharmaceutical preparations for medical use, namely use in gene therapy; Biochemicals, namely, biochemical reagent preparations for medical use, namely, for use in gene therapy; genetic material for medical use, namely, genetically engineered tissue for transplant purposes for genetic cell therapy

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 28, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 28, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 13, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 13, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 3, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 13, 2025 MAFR
NEW APPLICATION ENTERED
Jun 13, 2025 NWAP